Vor Biopharma Stock Forecast

Stock Price Forecast

The 7 analysts that cover Vor Biopharma stock have a consensus rating of "Buy" and an average price target of $3.77, which forecasts a 41.2% increase in the stock price over the next year. The lowest target is $0.4 and the highest is $8.

Price Target: $3.77 (+41.2%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.40	$3.77	$3.00	$8.00
Change	-85.02%	+41.20%	+12.36%	+199.63%

Analyst Ratings

The average analyst rating for Vor Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	2	2	1	2
Buy	5	5	5	5	4	2
Hold	0	0	0	0	2	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $3	Hold → Strong Buy	Upgrades	$3	+12.36%	Jun 30, 2025
Jack Allen Baird	Baird	Hold Maintains $0.25 → $1	Hold	Maintains	$0.25 → $1	-62.55%	Jun 27, 2025
David Nierengarten Wedbush	Wedbush	Hold Reiterates $0.4	Hold	Reiterates	$0.4	-85.02%	Jun 26, 2025
Silvan Tuerkcan JMP Securities	JMP Securities	Buy → Hold Downgrades $6	Buy → Hold	Downgrades	$6	+124.72%	May 9, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 139.37M

Revenue Next Year

n/a

EPS This Year

-0.71

from -1.70

EPS Next Year

-0.44

from -0.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	26.48M	67.90M	139.37M
Revenue Growth	-	-	-	156.37%	105.26%	-	-	-
EPS	-230.56	-2.10	-2.33	-1.75	-1.70	-0.71	-0.44	-0.67
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	102.2M
Avg	n/a	n/a	26.5M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.61	-0.07	-0.12
Avg	-0.71	-0.44	-0.67
Low	-0.93	-0.82	-1.24

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.